ZhiLong Wang

30PUBLICATIONS
12CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCardiology (incl. cardiovascular diseases)Epidemiological modellingNutrigenomics and personalised nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Jul 03, 2025
A Nearly 50% Risk of MACCE Cutdown by Personalized Antiplatelet Therapy: The Subgroup Analysis of Hypertension in PATH-PCI Trial.

Ting-Ting Wu, Ying-Ying Zheng, Zhi-Long Wang

|Sep 18, 2024
Association of the Triglyceride-Glucose Index With Resistant Hypertension and a Nomogram Model Construction.

Hai-Tao Yang, Jing-Kun Liu, Bang-Quan Liu

Pageof 5